Skip to contentClarengateINTELLIGENCE
Companies/10377830

Esox Biologics Ltd

Research and experimental development on biotechnology · London

ActiveUnited KingdomIncorporated 2016Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-09-30 · GBP · Company accounts

Net assets
−£1,379,661
Cash
£8,746
Turnover
—
Profit / loss
—
Current assets
£240,930
Creditors < 1 year
£1,395,466
Equity
—
Average employees
6

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

9 periods
Reported figures2025-09-30Company2024-09-30Company2023-09-30Company2022-09-302021-09-302020-09-302019-09-302018-09-302017-09-30
Balance sheet
Net assets−£1,379,661−£884,855−£418,464−£81,150−£28,209—£0£20£20
Equity————−£28,209—£0£20£20
Assets
Fixed assets————£0—£0——
Property, plant & equipment£45,460£24,158£15,573£2,599—————
Current assets£240,930£457,330£264,988£102,379£4,345————
Cash at bank£8,746£175,003£147,066£98,513—————
Liabilities
Creditors within one year£1,395,466£363,343£198,025£186,128£32,230————
Creditors after one year£270,585£1,003,000£501,000—£0————
Net current assets−£1,154,536£93,987£66,963−£83,749−£27,885————
Assets less current liabilities−£1,109,076£118,145£82,536−£81,150−£27,885—£0——
People
Average employees6551100——
Source evidenceView filing View filing View filing View filing View filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges

No charges available in our records.